Social Capital Suvretta Holdings Corp III Cl A (DNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNAC | ZTS | TAK | CTLT | JAZZ |
| Company | Social Capital Suvretta Holdings Corp III Cl A | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Catalent Inc | Jazz Pharma Plc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NASDAQ |
| Open | 9.47 | 170.45 | 13.34 | 56.34 | 110.14 |
| High | 10.55 | 171.69 | 13.41 | 56.63 | 111.55 |
| Low | 9.24 | 166.95 | 13.30 | 56.18 | 108.58 |
| Last | 9.28 | 167.07 | 13.37 | 56.50 | 110.01 |
| Change | -0.72 | -0.16 | +0.10 | +0.16 | +0.72 |
| % Change | -7.20% | -0.10% | +0.75% | +0.28% | +0.66% |
| Volume | 338,800 | 3,007,100 | 1,333,900 | 1,712,900 | 693,700 |
| 20-Day Average Volume | 377,750 | 4,574,185 | 1,625,240 | 1,599,560 | 606,065 |
| Previous Close | 10.00 | 167.23 | 13.27 | 56.34 | 109.29 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.78 | 156.63 | 13.30 | 56.19 | 110.43 |
| 20-Day Raw Stochastic | 49.60% | 82.82% | 47.40% | 60.68% | 50.81% |
| 20-Day Relative Strength | 42.67% | 52.97% | 44.05% | 54.92% | 41.99% |
| Weighted Alpha | -8.60 | -11.45 | -20.15 | +42.66 | -22.27 |
| Today's Opinion | 100% Sell | 56% Sell | 88% Sell | 56% Buy | 100% Sell |
| Previous Opinion | 16% Sell | 64% Sell | 100% Sell | 56% Buy | 100% Sell |
| Last Month's Opinion | 16% Buy | 56% Sell | 88% Sell | 96% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.50% since 07/01/22 | +5.46% since 04/26/24 | +2.61% since 04/26/24 | +1.04% since 04/26/24 | +0.50% since 04/26/24 |
| Low | 8.03 on 07/05/22 | 158.04 on 05/01/24 | 13.08 on 05/01/24 | 55.75 on 05/01/24 | 103.01 on 05/02/24 |
| High | 10.55 on 07/11/22 | 171.69 on 05/03/24 | 13.41 on 05/03/24 | 56.63 on 05/03/24 | 113.36 on 05/02/24 |
| 1-Month | |||||
| %Chg | -6.07% since 06/10/22 | +2.52% since 04/03/24 | -1.18% since 04/03/24 | -0.32% since 04/03/24 | -5.91% since 04/03/24 |
| Low | 8.03 on 07/05/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 55.42 on 04/19/24 | 103.01 on 05/02/24 |
| High | 10.55 on 07/11/22 | 171.69 on 05/03/24 | 13.77 on 04/08/24 | 57.20 on 04/11/24 | 118.01 on 04/04/24 |
| 3-Month | |||||
| %Chg | -5.98% since 04/11/22 | -11.62% since 02/02/24 | -6.37% since 02/02/24 | +3.65% since 02/02/24 | -10.49% since 02/02/24 |
| Low | 8.03 on 07/05/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 55.42 on 04/19/24 | 103.01 on 05/02/24 |
| High | 10.55 on 07/11/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 60.20 on 02/05/24 | 134.17 on 02/26/24 |
| 6-Month | |||||
| %Chg | -5.98% since 01/11/22 | +2.98% since 11/03/23 | -4.57% since 11/03/23 | +60.19% since 11/03/23 | -16.70% since 11/03/23 |
| Low | 8.03 on 07/05/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 32.38 on 11/13/23 | 103.01 on 05/02/24 |
| High | 10.55 on 07/11/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 60.20 on 02/05/24 | 134.48 on 11/07/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 237,939 | 76,410,976 | 42,313,872 | 10,225,030 | 6,935,031 |
| Shares Outstanding, K | 25,640 | 457,359 | 3,164,837 | 180,974 | 63,040 |
| Annual Sales | 0 | 8,544,000,000 | 29,803,340,000 | 4,263,000,000 | 3,834,200,000 |
| Annual Net Income | -2,320,000 | 2,344,000,000 | 2,345,930,000 | -256,000,000 | 414,830,000 |
| Last Quarter Sales | 0 | 2,213,000,000 | 7,556,070,000 | 1,024,000,000 | 1,011,940,000 |
| Last Quarter Net Income | -3,981,025 | 525,000,000 | 718,900,000 | -206,000,000 | 94,150,000 |
| 60-Month Beta | N/A | 0.86 | 0.56 | 1.18 | 0.63 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.38 on 05/02/24 | 0.51 on 02/01/24 | -0.24 on 02/09/24 | 2.68 on 05/01/24 |
| Latest Earnings Date | N/A | 05/02/24 | 05/09/24 | 06/10/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 31.03 | 6.81 | 0.00 | 7.57 |